Vulvodynia Treatment Market: Nerve Block to Grow in Popularity Among Women Owing to Growing Depression Cases: Global Industry Analysis (2013 - 2017) & Opportunity Assessment (2018 - 2028)
- Healthcare, Pharmaceuticals and Medical devices
- No. of Pages : 246
- Format :
- Published : Mar, 2018
- Report Code : REP-GB-4985
An Incisive, In-depth Analysis on the Vulvodynia Treatment Market
This study offers a comprehensive, 360 degree analysis on the Vulvodynia Treatment market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Vulvodynia Treatment market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
There is an increasing tendency of women who have observed chronic vulvar pain once in a lifetime. If the pain is persistent for more than three months and has no apparent cause, it is called vulvodynia. It is estimated that 16% of women in the U.S. will have Vulvodynia at some point in their lives. According to the National Center for Biotechnology Information, U.S. National Library of Medicine, 17.9% of women reported symptoms suggestive of past Vulvodynia in 2013. Based on an analysis, 101,007 women in the 4-county area are estimated to have vulvar pain consistent with Vulvodynia, with another 218,219 having a history of such pain that has since resolved. As a result of these factors, the demand for the drugs is constantly rising. The drug type and its use is measured by the level of pain that is caused of vulvodynia. Although it is a chronic disease, at times even the minutest of pain can cause depression and anxiety among women.
Anticonvulsant to be the most used drug
Anticonvulsant is a type of medication that is used for controlling seizures or stop an ongoing series of seizures (convulsions). In Vulvodynia treatment, anticonvulsant is the most prescribed drug. Gabapentin is most reliable anticonvulsant drug available in vulvodynia treatment. Gabapentin is a drug which has long been recognized in chronic pain management as an effective way of curing pain. It contains tablets taken by mouth and works well for pain related to the nerve. The tablets are prescribed for a number of conditions impacting the central nervous system and they influence pain at the level of the spinal cord. Pregabalin is another anticonvulsant drug. It is very similar to gabapentin; however, it is reported to have fewer side effects and is possibly more operative.
Tricyclic antidepressant to rise in consumption
Tricyclic antidepressants (TCAs) are a class of medications that are used primarily as antidepressants. These can be prescribed by your doctor in doses lower than those used to treat depression. The drugs are used because they alter the way in which the nerve fibres transmit the sensation of pain, not because the doctor thinks it's all in your mind. It is often necessary to continue with treatment for 3-6 months. Examples of tablets include amitriptyline, nortriptyline and dothiepin. Other antidepressants namely venlafaxine can also be tried. As the treatment of vulvodynia is mainly centred at placebo, antidepressants are the first of form of medical treatments given to a patient in case of minor pains.
Use of local anaesthetic to rise globally
Local anaesthetics are generally applied externally to the skin. This medication originates in a form of gel or cream. They may be used before sexual intercourse to provide short-term pain relief, or they can be used for extended periods. Local anaesthetic is used topically to introitus, which decrease hypersensitivity. This medication need to apply before intercourse or nightly on a cotton ball in the introitus. Lidocaine gel or cream is considered to be the best local anaesthetic cream or gel for vulvodynia.
Global Healthcare Sector Outlook
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.
Parent Indicators Healthcare
-
Current expenditure on health, % of gross domestic product
-
Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
-
Annual growth rate of current expenditure on health, per capita, in real terms
-
Out-of-pocket expenditure, % of current expenditure on health
-
Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
-
Physicians, Density per 1000 population (head counts)
-
Nurses, Density per 1000 population (head counts)
-
Total hospital beds, per 1000 population
-
Curative (acute) care beds, per 1000 population
-
Medical technology, Magnetic Resonance Imaging units, total, per million population
-
Medical technology, Computed Tomography scanners, total, per million population
Research Methodology
FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.
Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.
Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.
Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.
On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.
Standard Report Structure
-
Executive Summary
-
Market Definition
-
Macro-economic analysis
-
Parent Market Analysis
-
Market Overview
-
Forecast Factors
-
Segmental Analysis and Forecast
-
Regional Analysis
-
Competition Analysis
Market Taxonomy
The vulvodynia treatment market has been segmented on the following:
|
Drug Class |
Mode of Administration |
Distribution Channel |
Region |
|---|---|---|---|
|
|
|
|
Specific Report Inputs
The analyst has checked the prevalence of vulvodynia among the women of 18 to 45 years of age. The main countries in every region have been gauged to check the prevalence rate in every country. The co-morbidity rate has also been considered country-wise. The annual treatment cost along with the volume consumed has been taken into consideration to come to the data in the report.
Vulvodynia Treatment Market Reports - Table of Contents
12. Forecast Factors: Relevance and Impact
13. Forecast Assumptions
20. Assumptions and Acronyms Used
21. Research Methodology
Vulvodynia Treatment Market Reports - List of Tables
Table 01: North America Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2017 and Forecast 2018-2028 By Country
Table 02: North America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018-2028 By Drug Type
Table 03: North America Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2017 and Forecast 2018-2028, By mode of administration
Table 04: North America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 05: Latin America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country
Table 06: Latin America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Drug Type
Table 07: Latin America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By mode of administration
Table 08: Latin America Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 09: Western Europe Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2017 and Forecast 2018–2028, By Country
Table 10: Western Europe Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Drug Type
Table 11: Western Europe Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2017 and Forecast 2018–2028, By mode of administration
Table 12: Western Europe Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 13: Eastern Europe Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2017 and Forecast 2018–2028, By Country
Table 14: Eastern Europe Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Drug Type
Table 15: Eastern Europe Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2017 and Forecast 2018–2028, By mode of administration
Table 16: Eastern Europe Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 17: Asia Pacific Excluding Japan Vulvodynia Treatment Market size (US$ Mn) Analysis, 2013–2017 and Forecast 2018–2028, By Country
Table 18: Asia Pacific Excluding Japan Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Drug Type
Table 19: Asia Pacific Excluding Japan Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2017 and Forecast 2018–2028, By mode of administration
Table 20: Asia Pacific Excluding Japan Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 21: Japan Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Drug Type
Table 22: Japan Vulvodynia Treatment Market size (US$ Mn)Analysis-22013–2017 and Forecast 2018–2028, By mode of administration
Table 23: Japan Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 24: Middle East and Africa Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country
Table 25: Middle East and Africa Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Drug Type
Table 26: Middle East and Africa Vulvodynia Treatment Market size (US$ Mn)Analysis-2013–2017 and Forecast 2018–2028, By mode of administration
Table 27: Middle East and Africa Vulvodynia Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel
Table 28: Global Vulvodynia Treatment Market Size (US$ Mn) Forecast By Region, 2013-2018
Table 29: Global Vulvodynia Treatment Market Size Value (US$ Mn) Analysis 2012–2016 and Forecast 2018–2028 , By Drug Type
Table 30: Global Vulvodynia Treatment Market size (US$ Mn) Analysis 2018–2028 and Forecast 2017–2027, By Animal Type
Table 31: Global Vulvodynia Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2018–2028, By Distribution Channel
Vulvodynia Treatment Market Reports - List of Figures
Figure 01: Pain Description by Vulvodynia Patient
Figure 02: Pain Location in Vulvodynia Patient
Figure 03: Additional Conditions Suffered By Vulvodynia Patient
Figure 04: Vulvodynia Treatment Market Split By Country (2017)
Figure 05: Vulvodynia Treatment Market Split By Drug Class (2017)
Figure 06: Vulvodynia Treatment Market Split By Mode of Administration (2017)
Figure 07: Vulvodynia Treatment Market Split By Distribution Channel (2017)
Figure 08: North America Vulvodynia Treatment Market Size Analysis, 2013–2017
Figure 09: North America Vulvodynia Treatment Market Forecast & Y-o-Y growth, 2018–2028
Figure 10: U.S. Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2017
Figure 11: U.S. Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 12: Canada Vulvodynia Treatment, Market Size (US$ Mn) Analysis, 2013–2017
Figure 13: Canada Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 14: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 15: Anticonvulsant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 16: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 17: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 18: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 19: SNRIs Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 20: Hormone Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 21: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 22: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 23: Nerve Block Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 24: Local Anesthetic Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 25: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 26: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 27: Other Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 28: North America Vulvodynia Treatment Market Attractiveness Analysis By Country, 2018-2028
Figure 29: North America Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2018-2028
Figure 30: North America Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2018-2028
Figure 31: North America Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2018-2028
Figure 32: Vulvodynia Treatment Market Split By Country (2017)
Figure 33: Vulvodynia Treatment Market Split By Drug Class (2017)
Figure 34: Vulvodynia Treatment Market Split By Mode of Administration (2017)
Figure 35: Vulvodynia Treatment Market Split By Distribution Channel (2017)
Figure 36: Latin America Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 37: Latin America Vulvodynia Treatment Market Forecast & Y-o-Y growth, 2018-2028
Figure 38: Brazil Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 39: Brazil Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 40: Mexico Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 41: Mexico Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 42: Rest of Latin America Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 43: Rest of Latin America Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 44: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 45: Anticonvulsant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 46: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 47: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 48: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 49: SNRIs Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 50: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2013–2017
Figure 51: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 52: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 53: Nerve Block Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 54: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2013–2017
Figure 55: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 56: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 57: Other Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018-2028
Figure 58: Latin America Vulvodynia Treatment Market Attractiveness Analysis By Country, 2018-2028
Figure 59: Latin America Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2018-2028
Figure 60: Latin America Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2018-2028
Figure 61: Latin America Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2018-2028
Figure 62: Vulvodynia Treatment Market Split By Country (2017)
Figure 63: Vulvodynia Treatment Market Split By Drug Class (2017)
Figure 64: Vulvodynia Treatment Market Split By Mode of Administration (2017)
Figure 65: Vulvodynia Treatment Market Split By Distribution Channel (2017)
Figure 66: Western Europe Vulvodynia Treatment Market Size Analysis, 2013–2017
Figure 67: Western Europe Vulvodynia Treatment Market Forecast & Y-o-Y growth, 2018–2028
Figure 68: U.K. Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2017
Figure 69: U.K. Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 70: Germany Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2017
Figure 71: Germany Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 72: France Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2017
Figure 73: France Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 74: Spain Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2017
Figure 75: Spain Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 76: Italy Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2017
Figure 77: Italy Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 78: Rest of Western Europe Vulvodynia Treatment , Market Size (US$ Mn) Analysis, 2013–2017
Figure 79: Rest of Western Europe Vulvodynia Treatment , Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 80: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 81: Anticonvulsant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 82: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 83: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 84: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 85: SNRIs Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 86: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2013–2017
Figure 87: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 88: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 89: Nerve Block Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 90: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2013–2017
Figure 91: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 92: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 93: Other Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 94: Western Europe Vulvodynia Treatment Market Attractiveness Analysis By Country, 2018–2028
Figure 95: Western Europe Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2018–2028
Figure 96: Western Europe Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2018–2028
Figure 97: Western Europe Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 98: Vulvodynia Treatment Market Split By Country (2017)
Figure 99: Vulvodynia Treatment Market Split By Drug Class (2017)
Figure 100: Vulvodynia Treatment Market Split By Mode of Administration (2017)
Figure 101: Vulvodynia Treatment Market Split By Distribution Channel (2017)
Figure 102: Eastern Europe Vulvodynia Treatment Market Size Analysis, 2013–2017
Figure 103: Eastern Europe Vulvodynia Treatment Market Forecast & Y-o-Y growth, 2018–2028
Figure 104: Russia Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 105: Russia Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 106: Poland Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 107: Poland Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 108: Rest of Eastern Europe Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 109: Rest of Eastern Europe Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 110: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 111: Anticonvulsant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 112: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 113: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 114: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 115: SNRIs Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 116: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 117: Hormone Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 118: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 119: Nerve Block Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 120: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 121: Local Anesthetic Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 122: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 123: Other Vulvodynia Treatment Market Forecast & Y-o-Y Growth (%), 2018–2028
Figure 124: Eastern Europe Vulvodynia Treatment Market Attractiveness Analysis By Country, 2018–2028
Figure 125: Eastern Europe Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2018–2028
Figure 126: Eastern Europe Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2018–2028
Figure 127: Eastern Europe Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 128: Vulvodynia Treatment Market Split By Country (2017)
Figure 129: Vulvodynia Treatment Market Split By Drug Class (2017)
Figure 130: Vulvodynia Treatment Market Split By Mode of Administration (2017)
Figure 131: Vulvodynia Treatment Market Split By Distribution Channel (2017)
Figure 132: Asia Pacific Excluding Japan Vulvodynia Treatment Market Size Analysis (US$ Mn), 2013–2017
Figure 133: Asia Pacific Excluding Japan Vulvodynia Treatment Market Forecast (US$ Mn) (US$ Mn) & Y-o-Y growth (%), 2018–2028
Figure 134: China Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 135: China Vulvodynia Treatment Market Forecast (US$ Mn) (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 136: India Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 137: India Vulvodynia Treatment Market Forecast (US$ Mn) (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 138: Australia and New Zealand Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 139: Australia and New Zealand Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 140: Rest of APEJ Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 141: Rest of APEJ Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 142: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 143: Anticonvulsant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 144: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 145: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 146: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 147: SNRIs Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 148: Hormone Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 149: Hormone Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 150: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 151: Nerve Block Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 152: Local Anesthetic Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 153: Local Anesthetic Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 154: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 155: Other Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 156: Asia Pacific Excluding Japan Vulvodynia Treatment Market Attractiveness Analysis By Country, 2018–2028
Figure 157: Asia Pacific Excluding Japan Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2018–2028
Figure 158: Asia Pacific Excluding Japan Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2018–2028
Figure 159: Asia Pacific Excluding Japan Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 160: Vulvodynia Treatment Market Split By Drug Class (2017)
Figure 161: Vulvodynia Treatment Market Split By Mode of Administration (2017)
Figure 162: Vulvodynia Treatment Market Split By Distribution Channel (2017)
Figure 163: Japan Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 164: Japan Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y growth, 2018–2028
Figure 165: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 166: Anticonvulsant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 167: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 168: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 169: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 170: SNRIs Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 171: Hormone Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 172: Hormone Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 173: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 174: Nerve Block Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 175: Local Anesthetic Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 176: Local Anesthetic Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 177: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 178: Other Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 179: Japan Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2018–2028
Figure 180: Japan Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2018–2028
Figure 181: Japan Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 182: Vulvodynia Treatment Market Split By Country (2017)
Figure 183: Vulvodynia Treatment Market Split By Drug Class (2017)
Figure 184: Vulvodynia Treatment Market Split By Mode of Administration (2017)
Figure 185: Vulvodynia Treatment Market Split By Distribution Channel (2017)
Figure 186: Middle East and Africa Vulvodynia Treatment Market Size Analysis, 2013–2017
Figure 187: Middle East and Africa Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y growth, 2018–2028
Figure 188: GCC Countries Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 189: GCC Countries Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 190: South Africa Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 191: South Africa Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 192: Rest of MEA Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 193: Rest of MEA Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 194: Anticonvulsant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 195: Anticonvulsant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 196: Tricyclic Antidepressant Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 197: Tricyclic Antidepressant Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 198: SNRIs Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 199: SNRIs Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 200: Hormone Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 201: Hormone Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 202: Nerve Block Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 203: Nerve Block Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 204: Local Anesthetic Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 205: Local Anesthetic Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 206: Other Vulvodynia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 207: Other Vulvodynia Treatment Market Forecast (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 208: Middle East and Africa Vulvodynia Treatment Market Attractiveness Analysis By Country, 2018–2028
Figure 209: Middle East and Africa Vulvodynia Treatment Market Attractiveness Analysis By Drug Class, 2018–2028
Figure 210: Middle East and Africa Vulvodynia Treatment Market Attractiveness Analysis By Mode of Administration, 2018–2028
Figure 211: Middle East and Africa Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 212: Global Vulvodynia Treatment Market Attractiveness Analysis By Region, 2018–2028
Figure 213: Global Vulvodynia Treatment Market Attractiveness Analysis By Drug Type, 2018–2028
Figure 214: Global Vulvodynia Treatment Market Attractiveness Analysis By Animal Type, 2018–2028
Figure 215: Global Vulvodynia Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028
Figure 216: Global Vulvodynia Treatment Market Value Analysis and Forecast, 2017–2028 (US$ Mn
Figure 217: Global Vulvodynia Treatment Market Absolute $ Opportunity (US$ Mn), 2017–2028
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.